Oramed to Present at Conferences in May
NEW YORK, May 7, 2018 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will present at three conferences over the next two weeks. DG Disruptive Growth and Healthcare Conference, panel discussion and corporate presentation Date: May 8, […]
